152 related articles for article (PubMed ID: 1652350)
1. Intravenous immunoglobulin in bone marrow transplantation.
Gale RP; Winston D
Cancer; 1991 Sep; 68(6 Suppl):1451-3. PubMed ID: 1652350
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
Sullivan KM; Kopecky KJ; Jocom J; Fisher L; Buckner CD; Meyers JD; Counts GW; Bowden RA; Peterson FB; Witherspoon RP
N Engl J Med; 1990 Sep; 323(11):705-12. PubMed ID: 2167452
[TBL] [Abstract][Full Text] [Related]
3. Successful strategy for prevention of cytomegalovirus interstitial pneumonia after human leukocyte antigen-identical bone marrow transplantation.
Elfenbein GJ; Siddiqui T; Rand KH; Graham-Pole J; Marcus RB; Mendenhall NP; Goedert TM; Wikle-Fisher T; Gross SA; Weiner RS
Rev Infect Dis; 1990; 12 Suppl 7():S805-10. PubMed ID: 2173109
[TBL] [Abstract][Full Text] [Related]
4. Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.
Feinstein LC; Seidel K; Jocum J; Bowden RA; Anasetti C; Deeg HJ; Flowers ME; Kansu E; Martin PJ; Nash RA; Storek J; Etzioni R; Applebaum FR; Hansen JA; Storb R; Sullivan KM
Biol Blood Marrow Transplant; 1999; 5(6):369-78. PubMed ID: 10595814
[TBL] [Abstract][Full Text] [Related]
5. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases].
Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E
Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease.
Sullivan KM
Clin Exp Immunol; 1996 May; 104 Suppl 1():43-8. PubMed ID: 8625543
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation.
Winston DJ; Ho WG; Lin CH; Bartoni K; Budinger MD; Gale RP; Champlin RE
Ann Intern Med; 1987 Jan; 106(1):12-8. PubMed ID: 3024542
[TBL] [Abstract][Full Text] [Related]
8. Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.
Siadak MF; Kopecky K; Sullivan KM
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):53-7. PubMed ID: 8033436
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infections after allogeneic bone marrow transplantation.
Winston DJ; Ho WG; Champlin RE
Rev Infect Dis; 1990; 12 Suppl 7():S776-92. PubMed ID: 2173107
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.
Schmidt GM; Horak DA; Niland JC; Duncan SR; Forman SJ; Zaia JA
N Engl J Med; 1991 Apr; 324(15):1005-11. PubMed ID: 1848679
[TBL] [Abstract][Full Text] [Related]
11. CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
Patton WN; Carter C; Bienz N; Lamb T; Boughton BJ; Franklin IM
Bone Marrow Transplant; 1991; 7 Suppl 2():44. PubMed ID: 1652330
[No Abstract] [Full Text] [Related]
12. [Risk factors for the occurrence of pneumonia caused by cytomegaloviruses in patients with bone marrow transplants during prevention with cytomegalovirus hyperimmune globulin].
Schmeiser T; Heit W
Immun Infekt; 1985 Nov; 13(6):302-6. PubMed ID: 3000924
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation.
Sokos DR; Berger M; Lazarus HM
Biol Blood Marrow Transplant; 2002; 8(3):117-30. PubMed ID: 11939601
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s.
Winston DJ; Gale RP
Bone Marrow Transplant; 1991 Jul; 8(1):7-11. PubMed ID: 1655140
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cytomegalovirus disease.
Emanuel D
Semin Hematol; 1990 Apr; 27(2 Suppl 1):22-7; discussion 28-9. PubMed ID: 2160128
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.
Bass EB; Powe NR; Goodman SN; Graziano SL; Griffiths RI; Kickler TS; Wingard JR
Bone Marrow Transplant; 1993 Sep; 12(3):273-82. PubMed ID: 8241987
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.
Snydman DR
Rev Infect Dis; 1990; 12 Suppl 7():S839-48. PubMed ID: 2173113
[TBL] [Abstract][Full Text] [Related]
19. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
[TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.
Zaia JA
Clin Infect Dis; 1993 Nov; 17 Suppl 2():S392-9. PubMed ID: 8274605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
